Filing Details
- Accession Number:
- 0000014272-16-000432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-30 17:42:38
- Reporting Period:
- 2016-06-28
- Filing Date:
- 2016-06-30
- Accepted Time:
- 2016-06-30 17:42:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208099 | Lamberto Andreotti | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2016-06-28 | 10,500 | $71.40 | 403,094 | No | 4 | S | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2016-06-28 | 1,100 | $71.94 | 401,994 | No | 4 | S | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2016-06-29 | 9,800 | $72.79 | 392,194 | No | 4 | S | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2016-06-28 | 1,800 | $73.09 | 390,394 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 100,000 | Indirect | 2015 Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2015.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $70.83 to $71.81, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.85 to $72.06, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $72.04 to $73.03, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $73.05 to $73.16, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.